Stand Up To Cancer Logo

SU2C-Lustgarten Foundation Research Team Aims To Apply CAR T-cell Therapy to Pancreatic Cancer

PHILADELPHIA – July 27, 2017—Stand Up To Cancer (SU2C) is supporting a new translational research team to explore how a type of immunotherapy that has been very successful in blood cancers can be applied to pancreatic cancer, the American Association for Cancer Research, SU2C’s Scientific Partner, announced today. The approach is called chimeric antigen receptor…